Refining the treatment parameters of diabetic retinopathy: new prospects and limitations on the horizon

J Diabetes Complications. Mar-Apr 2014;28(2):119. doi: 10.1016/j.jdiacomp.2013.11.001. Epub 2013 Nov 12.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Blood Glucose / metabolism*
  • Diabetic Retinopathy / drug therapy*
  • Diabetic Retinopathy / metabolism*
  • Female
  • Humans
  • Macular Edema / drug therapy*
  • Male
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Blood Glucose
  • Vascular Endothelial Growth Factor A
  • Bevacizumab